This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (31)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

DAN W. ELLIOTT, M.D.

AMA Arch Surg. 1957;75(4):573-580.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Experience with acute pancreatitis over a 10-year period has been analyzed to evaluate the results of current therapy, and particularly the addition of concentrated albumin to customary treatment. During the same period blood volume determinations have shown marked deficits, in patients with pancreatitis, resulting in earlier and more liberal administration of whole blood. The results indicate that albumin together with whole blood has become the only important addition to the treatment of acute pancreatitis in this hospital during the past 10 years.

The administration of concentrated albumin to patients with pancreatitis followed the success reported from this treatment by Kenwell and Wels in February, 1953.¹ They gave 300 to 500 cc. per day, for three to five days, to 11 patients operated on for severe hemorrhagic pancreatitis without a fatality. They attributed the benefit from albumin therapy to the inhibition of trypsin by concentration of the normal plasma trypsin . . . [Full Text PDF of this Article]

Author Affiliations
Columbus, Ohio

From the Department of Surgery, Ohio State University College of Medicine and Ohio State University Hospital.

Footnotes
Submitted for publication March 4, 1957.

Aided in part by a grant from the National Institutes of Health, Bethesda, Md.

Read at the 14th Annual Meeting of the Central Surgical Association, Chicago, Feb. 22, 1957.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?